Cargando…
Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
It is well-established that following ingestion of aspirin or any other inhibitor of cyclooxygenase-1, patients with Samter's disease, or aspirin-exacerbated respiratory disease (AERD) develop the sudden onset of worsening respiratory clinical symptoms, which usually involves nasal congestion,...
Autor principal: | Laidlaw, Tanya M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251957/ https://www.ncbi.nlm.nih.gov/pubmed/30506046 http://dx.doi.org/10.1016/j.wjorl.2018.08.001 |
Ejemplares similares
-
Update on the Management of Aspirin-Exacerbated Respiratory Disease
por: Buchheit, Kathleen M., et al.
Publicado: (2016) -
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021) -
Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
por: Schneider, Sven, et al.
Publicado: (2023) -
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023) -
The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
por: Buchheit, Kathleen, et al.
Publicado: (2020)